Cargando…

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

In the last decades, we have progressively observed an improvement in therapeutic options for metastatic colorectal cancer (mCRC) treatment with a progressive prolongation of survival. mCRC prognosis still remains poor with low percentage of 5-year survival. Targeted agents have improved results obt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Guido, Febbraro, Antonio, Venditti, Michele, Campidoglio, Serena, Olivieri, Nunzio, Raieta, Katia, Parcesepe, Pietro, Imbriani, Giusy Carmen, Remo, Andrea, Pancione, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130202/ https://www.ncbi.nlm.nih.gov/pubmed/25136356 http://dx.doi.org/10.1155/2014/526178

Ejemplares similares

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches
por: Parente, Paola, et al.
Publicado: (2018)

Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer
por: Parcesepe, Pietro, et al.
Publicado: (2016)

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
por: Giordano, Guido, et al.
Publicado: (2017)

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2015)

Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era
por: Giordano, Guido, et al.
Publicado: (2021)

Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process
por: Pancione, Massimo, et al.
Publicado: (2021)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
por: Pancione, Massimo, et al.
Publicado: (2014)

Immune Resistance and EGFR Antagonists in Colorectal Cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Systems biology analysis of gene expression data and gene network reverse-engineering approaches reveal NFAT5 as a candidate biomarker in Inflammatory Breast Cancer
por: Remo, Andrea, et al.
Publicado: (2015)

Aflibercept in the Treatment of Metastatic Colorectal Cancer
por: Wang, Tzu-Fei, et al.
Publicado: (2012)

Ziv-aflibercept in metastatic colorectal cancer
por: Patel, Anuj, et al.
Publicado: (2013)

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression
por: Pancione, Massimo, et al.
Publicado: (2012)

Ziv-Aflibercept Use in Metastatic Colorectal Cancer
por: Rodriguez, Mabel
Publicado: (2013)

Network analysis and the impact of Aflibercept on specific mediators of angiogenesis in HUVEC cells
por: Latifi‐Navid, Hamid, et al.
Publicado: (2021)

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
por: Remo, Andrea, et al.
Publicado: (2015)

Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells
por: Yazdanyar, Amirfarbod, et al.
Publicado: (2023)

Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes
por: Remo, Andrea, et al.
Publicado: (2019)

Molecular and Clinical Insights in Malignant Brenner Tumor of the Testis With Liver Metastases:A Case Report
por: Parcesepe, Pietro, et al.
Publicado: (2021)

Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept
por: Dietvorst, Maria H. P., et al.
Publicado: (2013)

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer
por: Carola, Candice, et al.
Publicado: (2018)

Single-cell proteo-genomic reveals a comprehensive map of centrosome-associated spliceosome components
por: Cerulo, Luigi, et al.
Publicado: (2023)

Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience
por: Lavacchi, Daniele, et al.
Publicado: (2021)

Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept
por: de Oliveira Dias, João Rafael, et al.
Publicado: (2016)

The role of microenvironment in tumor angiogenesis
por: Jiang, Xianjie, et al.
Publicado: (2020)

Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer
por: Devaux, Madeline, et al.
Publicado: (2019)

Catheter-related Bacteremia and Multidrug-resistant Acinetobacter lwoffii
por: Tega, Luciano, et al.
Publicado: (2007)

Targeting the Tumor Microenvironment: Focus on Angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2012)

Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure
por: Aggarwal, Shyam
Publicado: (2015)

Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases
por: Alcaide, Julia, et al.
Publicado: (2016)

Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer
por: Hamaguchi, Tetsuya, et al.
Publicado: (2019)

Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
por: Watanabe, Jun, et al.
Publicado: (2022)

Multifocal gastrointestinal stromal tumor: A case report with CT, surgical, and histopathologic correlation
por: Brogna, Barbara, et al.
Publicado: (2019)

Ziv-aflibercept in macular disease
por: Mansour, Ahmad M, et al.
Publicado: (2015)

Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
por: Miyakubo, Tomoko, et al.
Publicado: (2023)

Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPARγ and TNFα Signaling
por: Pagnotta, Stefano Maria, et al.
Publicado: (2013)

Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis
por: Celus, Ward, et al.
Publicado: (2017)

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
por: He, Kuifeng, et al.
Publicado: (2012)

Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
por: Iozzo, Renato V, et al.
Publicado: (2011)

The role of tumour microenvironment in gastric cancer angiogenesis
por: Brzozowa, Marlena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c2jf6lj87ief9p72ho0cg41hjc